Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3846252 | Advances in Chronic Kidney Disease | 2016 | 8 Pages |
Abstract
Prolonged intermittent renal replacement therapy (PIRRT) is becoming an increasingly popular alternative to continuous renal replacement therapy in critically ill patients with acute kidney injury. There are significant practice variations in the provision of PIRRT across institutions, with respect to prescription, technology, and delivery of therapy. Clinical trials have generally demonstrated that PIRRT is non-inferior to continuous renal replacement therapy regarding patient outcomes. PIRRT offers cost-effective renal replacement therapy along with other advantages such as early patient mobilization and decreased nursing time. However, due to lack of standardization of the procedure, PIRRT still poses significant challenges, especially pertaining to appropriate drug dosing. Future guidelines and clinical trials should work toward developing consensus definitions for PIRRT and ensure optimal delivery of therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Fahad Edrees, Tingting Li, Anitha Vijayan,